Lead Rich International

Lead Rich International Limited is a Hong Kong-based investment holding company that operates primarily within the biotechnology and life sciences industries. The company is most notably recognized as the parent entity and major stakeholder of Leadgene Biomedical, a Taiwanese firm specializing in the development of high-quality antibodies and recombinant proteins. Through its subsidiaries, Lead Rich International provides a comprehensive suite of products and services, including in vitro diagnostic (IVD) reagents, ELISA kits, and contract research services (CRO) for protein expression and antibody discovery. The company's offerings support a wide array of applications in academic research, clinical diagnostics, and pharmaceutical development. Lead Rich International plays a strategic role in managing the financial and international growth of its biotech assets, focusing on the expansion of diagnostic and therapeutic tools across global markets.